<VariationArchive VariationID="16495" VariationName="NM_000639.3(FASLG):c.473_556del (p.Met158_Glu185del)" VariationType="Deletion" Accession="VCV000016495" Version="4" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-07-29" DateCreated="2014-11-15" MostRecentSubmission="2022-10-01">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="31534" VariationID="16495">
      <GeneList>
        <Gene Symbol="FASLG" FullName="Fas ligand" GeneID="356" HGNC_ID="HGNC:11936" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>1q24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="172659103" stop="172666876" display_start="172659103" display_stop="172666876" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="172628184" stop="172636012" display_start="172628184" display_stop="172636012" Strand="+" />
          </Location>
          <OMIM>134638</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000639.3(FASLG):c.473_556del (p.Met158_Glu185del)</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>1q24.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="172665642" stop="172665725" display_start="172665642" display_stop="172665725" variantLength="84" positionVCF="172665641" referenceAlleleVCF="CATGCCTCTGGAATGGGAAGACACCTATGGAATTGTCCTGCTTTCTGGAGTGAAGTATAAGAAGGGTGGCCTTGTGATCAATGAA" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="172634782" stop="172634865" display_start="172634782" display_stop="172634865" variantLength="84" positionVCF="172634781" referenceAlleleVCF="CATGCCTCTGGAATGGGAAGACACCTATGGAATTGTCCTGCTTTCTGGAGTGAAGTATAAGAAGGGTGGCCTTGTGATCAATGAA" alternateAlleleVCF="C" />
      </Location>
      <OtherNameList>
        <Name>FASLG, 84-BP DEL, EX4</Name>
      </OtherNameList>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007269.1" sequenceAccession="NG_007269" sequenceVersion="1" change="g.11598_11681del">
            <Expression>NG_007269.1:g.11598_11681del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.10" sequenceAccession="NC_000001" sequenceVersion="10" change="g.172634783_172634866del" Assembly="GRCh37">
            <Expression>NC_000001.10:g.172634783_172634866del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.11" sequenceAccession="NC_000001" sequenceVersion="11" change="g.172665643_172665726del" Assembly="GRCh38">
            <Expression>NC_000001.11:g.172665643_172665726del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007269.1" sequenceAccession="NG_007269" sequenceVersion="1" change="g.11599_11682del">
            <Expression>NG_007269.1:g.11599_11682del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000639.3" sequenceAccession="NM_000639" sequenceVersion="3" change="c.473_556del" MANESelect="true">
            <Expression>NM_000639.3:c.473_556del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000630.1" sequenceAccession="NP_000630" sequenceVersion="1" change="p.Met158_Glu185del">
            <Expression>NP_000630.1:p.Met158_Glu185del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001302746.2" sequenceAccession="NM_001302746" sequenceVersion="2" change="c.*43_*126del">
            <Expression>NM_001302746.2:c.*43_*126del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001624" Type="3 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_58" sequenceAccession="LRG_58">
            <Expression>LRG_58:g.11599_11682del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="80358236" DB="dbSNP" />
        <XRef ID="CA126563" DB="ClinGen" />
        <XRef ID="nssv3761544" DB="dbVar" />
        <XRef ID="nsv1067834" DB="dbVar" />
        <XRef Type="Allelic variant" ID="134638.0001" DB="OMIM" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="public">Deletion of exon 4 from gene TNFSF6.</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000639.3(FASLG):c.473_556del (p.Met158_Glu185del) AND Autoimmune lymphoproliferative syndrome, type 1b" Accession="RCV000017959" Version="36">
        <ClassifiedConditionList TraitSetID="5421">
          <ClassifiedCondition DB="MedGen" ID="C1866120">Autoimmune lymphoproliferative syndrome, type 1b</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="1996-09-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000639.3(FASLG):c.473_556del (p.Met158_Glu185del) AND Autoimmune lymphoproliferative syndrome type 1" Accession="RCV001789750" Version="10">
        <ClassifiedConditionList TraitSetID="6277">
          <ClassifiedCondition DB="MedGen" ID="C1328840">Autoimmune lymphoproliferative syndrome type 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no classification provided</ReviewStatus>
            <Description SubmissionCount="1">not provided</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="1996-09-01" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2014-11-15" MostRecentSubmission="2022-10-01">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <CitationText>Lenardo, M. J. Personal Communication. 1999. Bethesda, Md.</CitationText>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">8787672</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="6277" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="369" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Autoimmune lymphoproliferative syndrome type 1, autosomal dominant</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Autoimmune lymphoproliferative syndrome type 1</ElementValue>
                <XRef ID="MONDO:0011158" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE I, AUTOSOMAL DOMINANT</ElementValue>
                <XRef Type="MIM" ID="601859" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">ALPS</ElementValue>
                <XRef Type="MIM" ID="601859" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Autoimmune lymphoproliferative syndrome (ALPS), caused by defective lymphocyte homeostasis, is characterized by the following: Non-malignant lymphoproliferation (lymphadenopathy, hepatosplenomegaly with or without hypersplenism) that often improves with age. Autoimmune disease, mostly directed toward blood cells. Lifelong increased risk for both Hodgkin and non-Hodgkin lymphoma. In ALPS-FAS (the most common and best-characterized type of ALPS, associated with heterozygous germline pathogenic variants in FAS), non-malignant lymphoproliferation typically manifests in the first years of life, inexplicably waxes and wanes, and then often decreases without treatment in the second decade of life; in many affected individuals, however, neither splenomegaly nor the overall expansion of lymphocyte subsets in peripheral blood decreases. Although autoimmunity is often not present at the time of diagnosis or at the time of the most extensive lymphoproliferation, autoantibodies can be detected before autoimmune disease manifests clinically. In ALPS-FAS caused by homozygous or compound heterozygous (biallelic) pathogenic variants in FAS, severe lymphoproliferation occurs before, at, or shortly after birth, and usually results in death at an early age. ALPS-sFAS, resulting from somatic FAS pathogenic variants in selected cell populations, notably the alpha/beta double-negative T cells (α/β-DNT cells), appears to be similar to ALPS-FAS resulting from heterozygous germline pathogenic variants in FAS, although lower incidence of splenectomy and lower lymphocyte counts have been reported in ALPS-sFAS and no cases of lymphoma have yet been published.</Attribute>
                <XRef ID="NBK1108" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301287</ID>
                <ID Source="BookShelf">NBK1108</ID>
              </Citation>
              <Citation Type="general" Abbrev="NIH, 2009">
                <ID Source="pmc">2953894</ID>
              </Citation>
              <XRef ID="3261" DB="Orphanet" />
              <XRef ID="C1328840" DB="MedGen" />
              <XRef ID="MONDO:0011158" DB="MONDO" />
              <XRef Type="MIM" ID="601859" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="5421" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="9370" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Autoimmune lymphoproliferative syndrome, type 1b</ElementValue>
                <XRef ID="Autoimmune+lymphoproliferative+syndrome%2C+type+1b/7777" DB="Genetic Alliance" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">ALPS1B</ElementValue>
                <XRef ID="601859" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">FASLG-Related Autoimmune Lymphoproliferative Syndrome</Attribute>
              </AttributeSet>
              <XRef ID="C1866120" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="38238" SubmissionDate="2014-11-11" DateLastUpdated="2014-11-15" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="134638.0001_AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE IB" title="FASLG, 84-BP DEL, EX4_AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE IB" />
        <ClinVarAccession Accession="SCV000038238" DateUpdated="2014-11-15" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1996-09-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a patient with SLE (152700) who exhibited lymphadenopathy, Wu et al. (1996) identified a heterozygous 84-bp deletion within exon 4 of the FASL gene, resulting in a predicted 28-amino acid in-frame deletion.</Attribute>
              <Citation>
                <ID Source="PubMed">8787672</ID>
              </Citation>
              <XRef DB="OMIM" ID="152700" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Lenardo (1999) suggested that this patient should be classified as having autoimmune lymphoproliferative syndrome (601859) due to mutation in the FASL gene. This form of ALPS has been designated ALPS1B, the form due to mutation in the FAS gene being ALPS1A.</Attribute>
              <Citation>
                <CitationText>Lenardo, M. J. Personal Communication. 1999. Bethesda, Md.</CitationText>
              </Citation>
              <XRef DB="OMIM" ID="601859" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FASLG" />
          </GeneList>
          <Name>FASLG, 84-BP DEL, EX4</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">84-BP DEL, EX4</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="134638.0001" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE IB</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3987607" SubmissionDate="2021-12-13" DateLastUpdated="2022-10-01" DateCreated="2021-12-18">
        <ClinVarSubmissionID localKey="NM_000639.1:c.472_555del|OMIM:601859" submittedAssembly="not applicable" />
        <ClinVarAccession Accession="SCV002032182" DateUpdated="2022-10-01" DateCreated="2021-12-18" Type="SCV" Version="2" SubmitterName="GeneReviews" OrgID="500062" OrganizationCategory="resource" OrgAbbreviation="GeneReviews" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no classification provided</ReviewStatus>
          <GermlineClassification>not provided</GermlineClassification>
          <Citation>
            <ID Source="PubMed">8787672</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000639.1:c.472_555del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1328840" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10794995</SubmissionName>
          <SubmissionName>SUB11808016</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="3987607" TraitType="Disease" MappingType="XRef" MappingValue="C1328840" MappingRef="MedGen">
        <MedGen CUI="C1328840" Name="Autoimmune lymphoproliferative syndrome type 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="38238" TraitType="Disease" MappingType="Name" MappingValue="AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE IB" MappingRef="Preferred">
        <MedGen CUI="C1866120" Name="Autoimmune lymphoproliferative syndrome, type 1b" />
      </TraitMapping>
    </TraitMappingList>
    <DeletedSCVList>
      <SCV>
        <Accession Version="2" DateDeleted="2014-12-03">SCV000040758 </Accession>
      </SCV>
    </DeletedSCVList>
  </ClassifiedRecord>
</VariationArchive>

